Efficacy and Safety of Dorner Tablets and Aspirin for Prevention of Arteriosclerosis Progress in Type 2 Diabetes Mellitus Patients

NCT02786979 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
190
Enrollment
INDUSTRY
Sponsor class

Stopped Upon interim analysis, sponsor's decision due to absence of demonstration of efficacy.

Conditions

Interventions

Sponsor

Astellas Pharma Inc